SUVEN PHARMACEUTICALS
Back to All Ratios
|
SUVEN PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| PCE(x) | 86.28 | 48.54 | 26.20 | 31.91 | 32.01 |
What is the latest Price to Cash Earnings (PCE) ratio of SUVEN PHARMACEUTICALS ?
| Year | Price to Cash Earnings (PCE) |
|---|---|
| Mar2025 | 86.28 |
| Mar2024 | 48.54 |
| Mar2023 | 26.20 |
| Mar2022 | 31.91 |
| Mar2021 | 32.01 |
How is Price to Cash Earnings (PCE) of SUVEN PHARMACEUTICALS Trending?
| Years | Price to Cash Earnings (PCE) | % Change | |
|---|---|---|---|
| Mar2025 | 86.28 | 77.75 | |
| Mar2024 | 48.54 | 85.27 | |
| Mar2023 | 26.2 | -17.89 | |
| Mar2022 | 31.91 | -0.31 | |
| Mar2021 | 32.01 | - | |
Other Financial Ratios of SUVEN PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Price to Cash Earnings (PCE) ratio of peers of SUVEN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN PHARMACEUTICALS | ₹13,920.9 Cr | -7.1% | 21.6% | -68.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹403,052.0 Cr | 0.3% | -3.7% | -4.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,336.0 Cr | 2.4% | 6.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,311.0 Cr | -0.8% | -1.5% | 25.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,264.0 Cr | 7.9% | 4.6% | 4.6% | Stock Analytics | |
| CIPLA | ₹105,484.0 Cr | 5.5% | 5.4% | -18.5% | Stock Analytics | |
SUVEN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN PHARMACEUTICALS | -7.1% |
21.6% |
-68.9% |
| SENSEX | -0.4% |
1.3% |
0.8% |
You may also like the below Video Courses